DK1680418T3 - Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika - Google Patents

Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika

Info

Publication number: DK1680418T3
Authority: DK; Denmark
Prior art keywords: alkyl; cycloalkyl; piperidinylmethyl; halo; alkoxy
Prior art date: 2003-10-17

Application number

DK04791552T

Other languages

English (en)

Inventor

Gihad Dargazanli

Genevieve Estenne-Bouhtou

Florence Medaisko

Maria-Carmen Renones

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-17

Filing date

2004-10-15

Publication date

2007-09-10

2004-10-15 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2007-09-10 Application granted granted Critical

2007-09-10 Publication of DK1680418T3 publication Critical patent/DK1680418T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Psychology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK04791552T 2003-10-17 2004-10-15 Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika DK1680418T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0312142A FR2861073B1 (fr)	2003-10-17	2003-10-17	Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
PCT/FR2004/002641 WO2005037781A2 (fr)	2003-10-17	2004-10-15	Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
DK1680418T3 true DK1680418T3 (da)	2007-09-10

Family

ID=34385235

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04791552T DK1680418T3 (da)	2003-10-17	2004-10-15	Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika

Country Status (26)

Country	Link
US (1)	US7335670B2 (da)
EP (1)	EP1680418B1 (da)
JP (1)	JP4696069B2 (da)
KR (1)	KR20060087598A (da)
CN (1)	CN100430394C (da)
AT (1)	ATE361923T1 (da)
AU (1)	AU2004281215B2 (da)
BR (1)	BRPI0415452A (da)
CA (1)	CA2542370A1 (da)
CY (1)	CY1106786T1 (da)
DE (1)	DE602004006431T2 (da)
DK (1)	DK1680418T3 (da)
ES (1)	ES2287782T3 (da)
FR (1)	FR2861073B1 (da)
HR (1)	HRP20070327T3 (da)
IL (1)	IL174941A (da)
MA (1)	MA28097A1 (da)
ME (1)	MEP22008A (da)
NO (1)	NO20062151L (da)
NZ (1)	NZ547165A (da)
PL (1)	PL1680418T3 (da)
PT (1)	PT1680418E (da)
RS (1)	RS20060316A (da)
RU (1)	RU2351596C2 (da)
WO (1)	WO2005037781A2 (da)
ZA (1)	ZA200603941B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2842804B1 (fr)	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861074B1 (fr) *	2003-10-17	2006-04-07	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
CN101072762B (zh) *	2004-12-09	2010-06-23	弗·哈夫曼-拉罗切有限公司	苯基-哌嗪甲酮衍生物
EP1874721A2 (en) *	2004-12-23	2008-01-09	Glaxo Group Limited	Glycine transport inhibitors
PE20061156A1 (es)	2004-12-23	2006-12-16	Glaxo Group Ltd	Derivados de benzamida como agentes inhibidores del transportador de glicina
GB0428233D0 (en) *	2004-12-23	2005-01-26	Glaxo Group Ltd	Compounds
TW200716531A (en)	2005-06-06	2007-05-01	Merck Sharp & Dohme	Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia
FR2906251B1 (fr) *	2006-09-22	2008-11-07	Sanofi Aventis Sa	Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique
DK1961735T3 (da) *	2007-02-22	2010-03-29	Indena Spa	Fremgangsmåde til fremstilling af (2R,3S)-3-phenylisoserinmethylesteracetatsalt
CN101784533B (zh)	2007-08-22	2013-08-21	艾博特股份有限两合公司	4-苄基氨基喹啉、含有它们的药物组合物和它们在治疗中的用途
ES2397764T3 (es)	2008-04-01	2013-03-11	Abbott Gmbh & Co. Kg	Tetrahidroisoquinolinas, composiciones farmacéuticas que las contienen, y su uso en terapia
WO2010087761A1 (en) *	2009-01-28	2010-08-05	Astrazeneca Ab	2-aza-bicyclo[2.2.2]octane compounds and uses thereof
TW201038569A (en)	2009-02-16	2010-11-01	Abbott Gmbh & Co Kg	Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (es)	2009-02-16	2011-03-30	Abbott Gmbh & Co Kg	Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
JP5618047B2 (ja) *	2010-01-29	2014-11-05	国立大学法人千葉大学	ポジトロン断層撮影法およびポジトロン放出化合物
KR101180174B1 (ko) *	2010-04-23	2012-09-05	동아제약주식회사	신규한 벤즈아미드 유도체
US8883839B2 (en)	2010-08-13	2014-11-11	Abbott Laboratories	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en)	2010-08-13	2015-06-09	AbbVie Deutschland GmbH & Co. KG	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en)	2010-08-13	2015-06-02	AbbVie Deutschland GmbH & Co. KG	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en)	2010-08-13	2014-09-30	Abbott Laboratories	Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en)	2010-08-13	2014-11-04	Abbott Laboratories	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en)	2011-05-12	2016-04-12	AbbVie Deutschland GmbH & Co. KG	Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8853196B2 (en)	2011-08-05	2014-10-07	AbbVie Deutschland GmbH & Co. KG	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CA2853254A1 (en)	2011-11-18	2013-05-23	Abbvie Inc.	N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2013075624A1 (zh) *	2011-11-22	2013-05-30	北京哈三联科技股份有限公司	甘氨酸重摄取抑制剂及其应用
EP2786986B1 (en) *	2011-11-29	2018-02-28	Vivozon, Inc.	Novel benzamide derivative and use thereof
US9365512B2 (en)	2012-02-13	2016-06-14	AbbVie Deutschland GmbH & Co. KG	Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en)	2013-03-15	2017-05-16	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en)	2013-03-15	2017-05-23	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004936A (es)	2013-10-17	2016-12-20	Abbvie Deutschland	Derivados de aminocromano, aminotiocromano y amino-1,2,3,4-tetrahi droquinilina, composiciones farmaceuticas que los contienen, y su uso en terapia.
CA2924699A1 (en)	2013-10-17	2015-04-23	AbbVie Deutschland GmbH & Co. KG	Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9550754B2 (en)	2014-09-11	2017-01-24	AbbVie Deutschland GmbH & Co. KG	4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
CN108218846A (zh) *	2016-12-22	2018-06-29	四川海思科制药有限公司	噻吩衍生物的新固态形式及其制备方法和用途
GB201714734D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714740D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714745D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714736D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201903832D0 (en)	2019-03-20	2019-05-01	Atrogi Ab	New compounds and methods
WO2020256456A1 (en) *	2019-06-20	2020-12-24	Vivozon Inc.	Method of preventing or treating postoperative pain
CN114478360B (zh) *	2022-02-10	2023-08-15	江苏海洋大学	一种苯甲酰胺类衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254569A (en) *	1991-01-14	1993-10-19	The Du Pont Merck Pharmaceutical Company	(Amidomethyl)nitrogen heterocyclic analgesics
JP3026845B2 (ja) *	1991-02-20	2000-03-27	日清製粉株式会社	ピペリジン誘導体
US6319920B1 (en) *	1998-02-27	2001-11-20	Syntex (U.S.A.) Llc	2-arylethyl-(piperidin-4-ylmethyl)amine derivatives
AU2001254546A1 (en) *	2000-04-20	2001-11-07	Nps Allelix Corp.	Aminopiperidines
FR2838739B1 (fr) *	2002-04-19	2004-05-28	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique
FR2842804B1 (fr) *	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique

2003
- 2003-10-17 FR FR0312142A patent/FR2861073B1/fr not_active Expired - Fee Related
2004
- 2004-10-15 KR KR1020067007372A patent/KR20060087598A/ko not_active Ceased
- 2004-10-15 DE DE602004006431T patent/DE602004006431T2/de not_active Expired - Lifetime
- 2004-10-15 ME MEP-220/08A patent/MEP22008A/xx unknown
- 2004-10-15 PL PL04791552T patent/PL1680418T3/pl unknown
- 2004-10-15 DK DK04791552T patent/DK1680418T3/da active
- 2004-10-15 WO PCT/FR2004/002641 patent/WO2005037781A2/fr not_active Ceased
- 2004-10-15 NZ NZ547165A patent/NZ547165A/en not_active IP Right Cessation
- 2004-10-15 RS YUP-2006/0316A patent/RS20060316A/sr unknown
- 2004-10-15 EP EP04791552A patent/EP1680418B1/fr not_active Expired - Lifetime
- 2004-10-15 HR HR20070327T patent/HRP20070327T3/xx unknown
- 2004-10-15 RU RU2006116887/04A patent/RU2351596C2/ru not_active IP Right Cessation
- 2004-10-15 AT AT04791552T patent/ATE361923T1/de active
- 2004-10-15 AU AU2004281215A patent/AU2004281215B2/en not_active Ceased
- 2004-10-15 CN CNB2004800338737A patent/CN100430394C/zh not_active Expired - Fee Related
- 2004-10-15 JP JP2006534798A patent/JP4696069B2/ja not_active Expired - Fee Related
- 2004-10-15 BR BRPI0415452-5A patent/BRPI0415452A/pt not_active IP Right Cessation
- 2004-10-15 PT PT04791552T patent/PT1680418E/pt unknown
- 2004-10-15 CA CA002542370A patent/CA2542370A1/fr not_active Abandoned
- 2004-10-15 ES ES04791552T patent/ES2287782T3/es not_active Expired - Lifetime
2006
- 2006-04-11 IL IL174941A patent/IL174941A/en not_active IP Right Cessation
- 2006-04-17 MA MA28942A patent/MA28097A1/fr unknown
- 2006-04-17 US US11/405,170 patent/US7335670B2/en not_active Expired - Fee Related
- 2006-05-12 NO NO20062151A patent/NO20062151L/no not_active Application Discontinuation
- 2006-05-16 ZA ZA200603941A patent/ZA200603941B/en unknown
2007
- 2007-08-02 CY CY20071101037T patent/CY1106786T1/el unknown

Also Published As

Publication number	Publication date
IL174941A0 (en)	2006-08-20
ES2287782T3 (es)	2007-12-16
IL174941A (en)	2011-12-29
DE602004006431D1 (de)	2007-06-21
MA28097A1 (fr)	2006-08-01
US7335670B2 (en)	2008-02-26
MEP22008A (en)	2010-06-10
KR20060087598A (ko)	2006-08-02
US20060223886A1 (en)	2006-10-05
RU2006116887A (ru)	2007-11-27
RS20060316A (sr)	2008-11-28
CY1106786T1 (el)	2012-05-23
EP1680418B1 (fr)	2007-05-09
AU2004281215A1 (en)	2005-04-28
CN100430394C (zh)	2008-11-05
ATE361923T1 (de)	2007-06-15
ZA200603941B (en)	2007-11-28
JP4696069B2 (ja)	2011-06-08
FR2861073A1 (fr)	2005-04-22
CA2542370A1 (fr)	2005-04-28
JP2007508359A (ja)	2007-04-05
AU2004281215B2 (en)	2010-09-30
EP1680418A2 (fr)	2006-07-19
WO2005037781A3 (fr)	2005-07-14
PL1680418T3 (pl)	2008-01-31
DE602004006431T2 (de)	2008-01-10
CN1882581A (zh)	2006-12-20
PT1680418E (pt)	2007-08-10
NO20062151L (no)	2006-05-12
NZ547165A (en)	2010-01-29
HK1098456A1 (zh)	2007-07-20
WO2005037781A2 (fr)	2005-04-28
FR2861073B1 (fr)	2006-01-06
RU2351596C2 (ru)	2009-04-10
BRPI0415452A (pt)	2006-12-19
HRP20070327T3 (en)	2007-09-30

Publication	Publication Date	Title
DK1680418T3 (da)	2007-09-10	Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika
FR2861071B1 (fr)	2006-01-06	Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
FR2861076B1 (fr)	2006-01-06	Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
IL174934A0 (en)	2006-08-20	Derivatives of n-[phenyl(pyrrolidine-2-yl) methyl] benzamide and n-[(azepan-2-yl) phenylmethyl] benzamide, preparation method thereof and application of same in therapeutics
PE20040993A1 (es)	2004-12-29	Derivados de taxano y de isotiazol referidos a enfermedades hiperproliferativas
PE20091573A1 (es)	2009-11-12	Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20090606A1 (es)	2009-06-17	Nuevos inhibidores de catepsina c y uso
RU2013145304A (ru)	2015-04-20	Производные изоксазола
PE20080906A1 (es)	2008-07-05	Derivados heteroarilo como inhibidores de citocina
NO20076498L (no)	2008-02-20	Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren
RU2009117209A (ru)	2010-11-20	2-пиридинкарбоксамидное производное, обладающее gk-активирующим действием
NZ590355A (en)	2013-01-25	Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
RU2378258C2 (ru)	2010-01-10	Производные сульфонамида
NO20075399L (no)	2007-12-19	Benzimidazolerivat og anvendelse derav
RU2011102396A (ru)	2012-07-27	Аминосоединения и их медицинское применение
ATE455772T1 (de)	2010-02-15	Alkinylarylcarbonsäureamide
CO5690599A2 (es)	2006-10-31	Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad
AR054417A1 (es)	2007-06-27	Derivados de imidazol. proceso de obtencion y composiciones farmaceuticas.
PE20061451A1 (es)	2007-01-22	Compuestos derivados de diarilsulfona sulfonamidas
EA201071299A1 (ru)	2011-06-30	5-[5-[2-(3,5-бис(трифторметил)фенил)-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил-2-алкилпролинамиды в качестве антагонистов рецептора nk1
CY1110613T1 (el)	2015-04-29	Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
EA200800352A1 (ru)	2008-06-30	Производные пирролопиридина и их применение в качестве модуляторов ppar-рецепторов
PT1789403E (pt)	2009-05-19	Derivados de n-(fenil-oxazol-4-ilmetoximetil)-ciclo-hexilsuccinamida e compostos relacionados como ligandos dos ppar (receptores activados de proliferadores de peroxisomas) para o tratamento da hiperlipidemia e diabetes
RU2009134224A (ru)	2011-03-20	Химические соединения
RU2013112560A (ru)	2014-10-10	Ингибиторы васе для применения в лечении диабета